As per the agreement terms, BullFrog AI will offer access to AI solutions to improve trial efficiency and patient outcomes.

In a recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98% specificity and 73% sensitivity across all stages.

The post Pancreatic Cancer Vaccine Shows Potential in Early Trial appeared first on Reason.com.

But sometimes life throws us curveballs, like a major health issue. It's no fun to navigate treatment for cancer or other ...

NovoCure remains a strong buy with robust earnings, growth in cancer treatments, and significant upside potential to Wall ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

ImmunityBio shares advanced 17% to $3.34 after the company said the Food and Drug Administration awarded a regenerative medicine advanced therapy designation for Anktiva and CAR-NK for the reversal of ...

BATON ROUGE, La. (WAFB) - Southern football safeties coach and former star player, Sean Wallace will be laid to rest Friday, Feb. 28. He was 52 when he passed away.

The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...

Tens of thousands of people need Creon to help them eat without having medical complications - but a shortage is said to be ...

Alpharetta Detective Brian Smith spent more than 19 years serving his community. He passed away this week after a battle with ...

Iowa's annual cancer report shows a troubling trend. What's making this year stand out and the concerns one cancer survivor ...